Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |